The 31st FAOBMB Conference & 2025 KSBMB International Conference (FAOBMB 2025) will be held from May 20 to 23 at BEXCO in Busan, South Korea. FAOBMB will bring together global experts in life sciences and biochemistry to share cutting-edge research and foster collaboration. Featuring distinguished speakers such as Nobel laureate Thomas C. Südhof and leaders from institutions like Harvard, MIT and Kyoto University, the conference will include symposia on 20 scientific topics, an industrial exhibition and a Young Scientist Program—offering valuable insights, hands-on experiences and rich networking opportunities in a vibrant coastal setting.
Come visit Chayon's booth No. 131, representing MaxCyte as our official distributor in Korea. Explore our cGMP-compliant, non-viral cell engineering platform and discover how MaxCyte enables the acceleration of therapeutic development from concept to clinic.
Featured presentation
SY07 Stem Cell and Cellular Identity
Wednesday, May 21, 2025, symposium from 2:00 - 4:00 p.m.
Dr. Takayama’s presentation: Stem Cell-Based Organ Models for Infectious Disease Research
Wednesday, May 21, 2025, from 3:40 - 3:55 p.m. in room 201-202
Abstract: Our experience with COVID-19 has underscored the importance of viral infection research and drug discovery efforts. Addressing a pandemic caused by a viral infection requires a thorough understanding of how the virus impacts the human body and the rapid development of therapeutic drugs to mitigate symptoms. Stem cell-based organoids and organ-on-a-chip technologies, which enable the recapitulation of structure and function of human organs in vitro, hold significant promise for accelerating research on viral infections. We previously developed respiratory organoids and airway/alveoli-on-a-chip, demonstrating their utility in infection studies with various respiratory viruses, including SARS-CoV-2, SARS-CoV, MERS-CoV, HCoV-229E, HCoV-OC43 and RSV. Our respiratory organoids and airway/alveoli-on-a-chip enable the identification of infected cells, as well as the analysis of innate immune responses, inflammatory responses and fibrosis. Furthermore, our model has the potential to facilitate the development of antiviral drugs. In addition to the respiratory models, we have recently developed intestinal and liver models and applied them to the study of viral infections. In this presentation, we will share the latest findings from our research on viral infections using stem cell-based organoids and organ-on-a-chip technologies.
Presenter
Breakfast workshop
The Application of MaxCyte's Scalable Transfection Platform to Non-Viral Gene Delivery and Other Applications
Presented by Suyoen Lee, PhD, Product Manager at CHAYON Laboratories, Inc., Korea
Thursday, May 22, 2025 from 8:00 - 8:50 a.m., in room 201-202
The pharmaceutical industry, biotechnology companies and related academic centers must efficiently identify, develop and quickly bring to market candidates—whether small molecule drugs, therapeutic proteins or vaccines—with the highest level of efficacy at the lowest cost. The MaxCyte transfection systems use fully scalable electroporation for rapid, highly efficient transfection. Through one instrument capable of both static and Flow Electroporation®, 75,000 to 20 billion cells can be transfected at once with greater than 90% efficiency and viability. Seamless scalability requires no re-optimization, so MaxCyte technology has been efficiently applied in the research stage (small scale) as well as in clinical production (large scale). Using more than 100 validated electroporation protocols, MaxCyte transfection systems are compatible with a broad array of cell types including mammalian, cancer, insect and human primary cells. In this presentation, Lee introduces MaxCyte's electroporation systems and their various applications, including basic cell-based assay development, protein production and cell and gene therapy.
